The first new sunscreen ingredient in more than 20 years just cleared a major federal hurdle, and it quietly rewrites how Americans can protect their skin from the sun.
Story Snapshot
- The Food and Drug Administration (FDA) moved to add bemotrizinol as a new sunscreen active ingredient after a full safety and effectiveness review.[1][3]
- Bemotrizinol blocks both UVA and UVB rays and shows very low absorption into the bloodstream in human trials.[1][2][3]
- Europe and other regions have used bemotrizinol in sunscreens for years, while Americans waited for the FDA process to catch up.[1]
- Doctors expect more comfortable sunscreens and stronger real-world protection once companies roll out new formulas built around this ingredient.
Why This New Sunscreen Ingredient Matters After Two Quiet Decades
The Food and Drug Administration did not add a single new sunscreen active ingredient to its official list for more than twenty years, even as skin cancer rates stayed high and other countries raced ahead with newer filters.[1]
That long pause ended when the agency proposed adding bemotrizinol, a modern filter that works against both ultraviolet A and ultraviolet B light and performs well in real skin tests.[1][3] This move signals not just another product, but a shift in how the system treats sun protection.
Bemotrizinol did not slide in on hype alone; the maker, DSM Nutritional Products, had to submit a full “over-the-counter monograph order request” asking the Food and Drug Administration to let companies use up to 6 percent bemotrizinol in drugstore sunscreens for adults and children older than six months.[3]
Agency scientists then pulled together lab data, animal tests, human skin studies, and real-use trials to decide whether this chemical deserved the label “generally recognized as safe and effective.”[2][3]
What The Food and Drug Administration Actually Found About Safety And Absorption
People worry, with good reason, about chemicals soaking through the skin and building up in the body, so regulators now demand real numbers instead of guesswork.[2]
To answer that, researchers ran skin-permeation tests and a “maximum usage” trial, where volunteers used a bemotrizinol sunscreen at full strength over large areas of their bodies.[2][3] Blood tests showed bemotrizinol either stayed below the Food and Drug Administration’s own concern threshold or dipped only briefly above it, with no sign of dangerous buildup over time.[2]
The U.S. just got its first new sunscreen in almost 20 years. Bemotrizinol is a powerful, broad-spectrum blocker of dangerous rays that has been used in Europe for years. https://t.co/DWxQ77SZYa pic.twitter.com/x3vuvyhGc5
— Yahoo News (@YahooNews) June 10, 2026
Beyond absorption, scientists checked for skin irritation, allergic reactions, and sunlight-triggered problems such as rashes from the mix of chemical plus ultraviolet exposure.[3]
Across repeat-exposure tests and the main human trial, there were only a few mild and one moderate side effect, and no serious events.[2][3] Toxicology studies also did not show signs that bemotrizinol causes cancer or harms development when used in normal sunscreen amounts, which is why the clinical review states that the ingredient is safe under the proposed conditions of use.[3]
How Bemotrizinol Changes Real-World Sun Protection For Families
Most American shoppers know the old standbys on a sunscreen label: zinc oxide, titanium dioxide, avobenzone, and a handful of tongue-twisting chemicals that chemists have worked with since the 1990s.
Bemotrizinol works differently; it is an oil-soluble filter that soaks up a wide range of ultraviolet A and ultraviolet B wavelengths, which lets chemists design products that feel lighter while still giving strong protection.[1] Many European brands already rely on it for high-number, broad-spectrum formulas that people are more willing to use every day.[1]
American doctors who follow sunscreen research see a clear upside in that shift. Better filters mean companies can offer high protection without the heavy, chalky texture that makes people avoid reapplying on hot days.
For parents trying to coat a squirming child, a smoother lotion that does not sting or leave white streaks can be the difference between regular use and a burned nose every weekend. From a common-sense view, tools that make it easier for families to protect their health without more mandates are a win.
Regulation, Delay, And The Push To Modernize Sunscreen Rules
Bemotrizinol also exposes how slowly the American system has moved compared with the rest of the developed world.[1][4] While Europe and other regions approved a slate of modern filters years ago, American makers sat on the sidelines because the Food and Drug Administration had not finished updating its rules and testing demands.[1][4] Industry groups and members of Congress criticized this delay, arguing that families were stuck with older chemistry even as new science showed better options.[4]
The FDA had approved the first new sunscreen ingredient in more than 25 years. The agency says it's safe for adults and children 6 months and older. https://t.co/h1cMhCspO4
— WWJ 950 (@WWJ950) June 9, 2026
The bemotrizinol case shows that when regulators set clear standards and follow the law’s process, they can both protect safety and allow innovation.[1][2][3]
The Food and Drug Administration now says that, under certain limits and up to 6 percent strength, bemotrizinol sunscreens are safe and effective drugs that do not require a prescription, and manufacturers are free to combine this filter with most other allowed sunscreen ingredients.[3] The remaining work will happen in factories and labs as companies build, test, and roll out better sunscreens to store shelves over the next several seasons.[1][4]
Sources:
[1] Web – FDA green-lights 1st new sunscreen ingredient in years
[2] Web – FDA approves new sunscreen ingredient for first time in decades
[3] Web – FDA Proposes Expanding Sunscreen Active Ingredient List
[4] Web – Here Comes the Sunscreen Ingredient the U.S. Has Been Waiting …
